Toxicological Reviews

, Volume 24, Issue 3, pp 205–214 | Cite as

Tricyclic Antidepressant Poisoning

Cardiovascular Toxicity
  • H. K. Ruben Thanacoody
  • Simon H. L. Thomas
Review Article

Abstract

Tricyclic antidepressants remain a common cause of fatal drug poisoning as a result of their cardiovascular toxicity manifested by ECG abnormalities, arrhythmias and hypotension. Dosulepin and amitriptyline appear to be particularly toxic in overdose. The principal mechanism of toxicity is cardiac sodium channel blockade, which increases the duration of the cardiac action potential and refractory period and delays atrioventricular conduction. Electrocardiographic changes include prolongation of the PR, QRS and QT intervals, nonspecific ST segment and T wave changes, atrioventricular block, right axis deviation of the terminal 40ms vector of the QRS complex in the frontal plane (T 40ms axis) and the Brugada pattern (downsloping ST segment elevation in leads V1–V3 in association with right bundle branch block). Maximal changes in the QRS duration and the T 40ms axis are usually present within 12 hours of ingestion but may take up to a week to resolve. Sinus tachycardia is the most common arrhythmia due to anticholinergic activity and inhibition of norepinephrine uptake by tricyclic antidepressants but bradyarrhythmias (due to atrioventricular block) and tachyarrhythmias (supraventricular and ventricular) may occur. Torsade de pointes occurs uncommonly. Hypotension results from a combination of reduced myocardial contractility and reduced systemic vascular resistance due to α-adrenergic blockade. Life-threatening arrhythmias and death due to tricyclic antidepressant poisoning usually occurs within 24 hours of ingestion. Rapid deterioration is common. Level of consciousness at presentation is the most sensitive clinical predictor of serious complications. Although a QRS duration >100ms and a rightward T 40ms axis appear to be better predictors of cardiovascular toxicity than the plasma tricyclic drug concentration, they have at best moderate sensitivity and specificity for predicting complications.

Notes

Acknowledgements

No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.

References

  1. 1.
    Bradberry SM, Thanacoody HKR, Watt BE, et al. Management of the cardiovascular complications of tricyclic antidepressant poisoning: role of sodium bicarbonate. Toxicol Rev 2005; 24(3): 195–204PubMedCrossRefGoogle Scholar
  2. 2.
    Thomas SHL, Bevan L, Bhattacharyya S, et al. Presentation of poisoned patients to accident and emergency departments in the North of England. Hum Exp Toxicol 1996; 15: 466–70PubMedCrossRefGoogle Scholar
  3. 3.
    Buckley NA, Whyte IM, Dawson AH, et al. Self-poisoning in Newcastle, 1987–1992. Med J Aust 1995; 162: 190–3PubMedGoogle Scholar
  4. 4.
    Obafunwa JO, Busuttil A. Deaths from substance overdose in the Lothian and Borders region of Scotland (1983–1991). Hum Exp Toxicol 1994; 13: 401–6PubMedCrossRefGoogle Scholar
  5. 5.
    Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ 1995; 310: 221–4PubMedCrossRefGoogle Scholar
  6. 6.
    Shah R, Uren Z, Baker A, et al. Deaths from antidepressants in England and Wales 1993–1997: analysis of a new national database. Psychol Med 2001; 31: 1203–10PubMedCrossRefGoogle Scholar
  7. 7.
    Glauser J. Tricyclic antidepressant poisoning. Cleve Clin J Med 2000; 67: 704–19PubMedGoogle Scholar
  8. 8.
    Buckley NA, Dawson AH, Whyte IM, et al. Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants. Lancet 1994; 343: 159–62PubMedCrossRefGoogle Scholar
  9. 9.
    Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. Q J Med 2003; 96: 369–74CrossRefGoogle Scholar
  10. 10.
    Buckley NA, McManus PR. Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ 2002; 325: 1332–3PubMedCrossRefGoogle Scholar
  11. 11.
    Dziukas LJ, Vohra J. Tricyclic antidepressant poisoning. Med J Aust 1991; 154: 344–50PubMedGoogle Scholar
  12. 12.
    Hurst HE, Jarboe CH. Clinical findings, elimination pharmacokinetics, and tissue drug concentrations following a fatal amitriptyline intoxication. J Toxicol Clin Toxicol 1981; 18: 119–25CrossRefGoogle Scholar
  13. 13.
    Spiker DG, Biggs JT. Tricyclic antidepressants: prolonged plasma levels after overdose. JAMA 1976; 236: 1711–2PubMedCrossRefGoogle Scholar
  14. 14.
    Vohra J, Burrows G, Hunt D, et al. The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction. Eur J Cardiol 1975; 3: 219–27PubMedGoogle Scholar
  15. 15.
    Teschemacher AG, Seward EP, Hancox JC, et al. Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline. Br J Pharmacol 1999; 128: 479–85PubMedCrossRefGoogle Scholar
  16. 16.
    Brennan FJ. Electrophysiologic effects of imipramine and doxepin on normal and depressed cardiac Purkinje fibers. Am J Cardiol 1980; 46: 599–606PubMedCrossRefGoogle Scholar
  17. 17.
    Steeds RP, Muthusamy R. Abnormal ventricular conduction following dothiepin overdose simulating acute myocardial infarction. Heart 2000; 83: 289PubMedCrossRefGoogle Scholar
  18. 18.
    Zakynthinos E, Vassilakopoulos T, Roussos C, et al. Abnormal atrial and ventricular repolarisation resembling myocardial injury after tricyclic antidepressant drug intoxication. Heart 2000; 83: 353–4PubMedCrossRefGoogle Scholar
  19. 19.
    Krayenbuehl P-A, Christen S. Tricyclic antidepressant overdose mimicking myocardial infarction. J Clin Basic Cardiol 2002; 5: 197Google Scholar
  20. 20.
    Chamsi-Pasha H, Barnes PC. Myocardial infarction: a complication of amitriptyline overdose. Postgrad Med J 1988; 64: 968–70PubMedCrossRefGoogle Scholar
  21. 21.
    Arya B, Hirudayaraj P, Willmer K. Myocardial infarction: a rare complication of dothiepin overdose. Int J Cardiol 2004; 96: 493–4PubMedCrossRefGoogle Scholar
  22. 22.
    Frommer DA, Kulig KW, Marx JA, et al. Tricyclic antidepressant overdose: a review. JAMA 1987; 257: 521–6PubMedCrossRefGoogle Scholar
  23. 23.
    Langou RA, Van Dyke C, Tahan SR, et al. Cardiovascular manifestations of tricyclic antidepressant overdose. Am Heart J 1980; 100: 458–64PubMedCrossRefGoogle Scholar
  24. 24.
    Pellinen TJ, Farkkila M, Heikkila J, et al. Electrocardiographic and clinical features of tricyclic antidepressant intoxication. Ann Clin Res 1987; 19: 12–7PubMedGoogle Scholar
  25. 25.
    Goldberg RJ, Capone RJ, Hunt JD. Cardiac complications following tricyclic antidepressant overdose: issues for monitoring policy. JAMA 1985; 254: 1772–5PubMedCrossRefGoogle Scholar
  26. 26.
    Niemann JT, Bessen HA, Rothstein RJ, et al. Electrocardiographic criteria for tricyclic antidepressant cardiotoxicity. Am J Cardiol 1986; 57: 1154–9PubMedCrossRefGoogle Scholar
  27. 27.
    Wolfe TR, Caravati EM, Rollins DE. Terminal 40-ms frontal plane QRS axis as a marker for tricyclic antidepressant overdose. Ann Emerg Med 1989; 18: 348–51PubMedCrossRefGoogle Scholar
  28. 28.
    Lavoie FW, Gansert GG, Weiss RE. Value of initial ECG findings and plasma drug levels in cyclic antidepressant overdose. Ann Emerg Med 1990; 19: 696–700PubMedCrossRefGoogle Scholar
  29. 29.
    Chow BJ, Gollob M, Birnie D. Brugada syndrome precipitated by a tricyclic antidepressant. Heart 2005; 91: 651PubMedCrossRefGoogle Scholar
  30. 30.
    Babaliaros VC, Hurst JW. Tricyclic antidepressants and the Brugada syndrome: an example of Brugada waves appearing after the administration of desipramine. Clin Cardiol 2002; 25: 395–8PubMedCrossRefGoogle Scholar
  31. 31.
    Bolognesi R, Tsialtas D, Vasini P, et al. Abnormal ventricular repolarization mimicking myocardial infarction after heterocyclic antidepressant overdose. Am J Cardiol 1997; 79: 242–5PubMedCrossRefGoogle Scholar
  32. 32.
    Tada H, Sticherling C, Oral H, et al. Brugada syndrome mimicked by tricyclic antidepressant overdose. J Cardiovasc Electrophysiol 2001; 12: 275PubMedCrossRefGoogle Scholar
  33. 33.
    Bigwood B, Galler D, Amir N, et al. Brugada syndrome following tricyclic antidepressant overdose. Anaesth Intensive Care 2005; 33: 266–70PubMedGoogle Scholar
  34. 34.
    Goldgran-Toledano D, Sideris G, Kevorkian J-P. Overdose of cyclic antidepressants and the Brugada syndrome. N Engl J Med 2002; 346: 1591–2PubMedCrossRefGoogle Scholar
  35. 35.
    Liebelt EL, Ulrich A, Francis PD, et al. Serial electrocardiogram changes in acute tricyclic antidepressant overdoses. Crit Care Med 1997; 25: 1721–6PubMedCrossRefGoogle Scholar
  36. 36.
    Shannon MW. Duration of QRS disturbances after severe tricyclic antidepressant intoxication. J Toxicol Clin Toxicol 1992; 30: 377–86PubMedCrossRefGoogle Scholar
  37. 37.
    Noble J, Matthew H. Acute poisoning by tricyclic antidepressants: clinical features and management of 100 patients. J Toxicol Clin Toxicol 1969; 2: 403–21CrossRefGoogle Scholar
  38. 38.
    Bramble MG, Lishman AH, Purdon J, et al. An analysis of plasma levels and 24-hour ECG recordings in tricyclic antidepressant poisoning: implications for management. Q J Med 1985; 56: 357–66PubMedGoogle Scholar
  39. 39.
    Fasoli RA, Glauser FL. Cardiac arrhythmias and ECG abnormalities in tricyclic antidepressant overdose. J Toxicol Clin Toxicol 1981; 18: 155–63CrossRefGoogle Scholar
  40. 40.
    Thorstrand C. Clinical features in poisonings by tricyclic antidepressants with special reference to the ECG. Acta Med Scand 1976; 199: 337–44PubMedCrossRefGoogle Scholar
  41. 41.
    Callaham M, Kassel D. Epidemiology of fatal tricyclic antidepressant ingestion: implications for management. Ann Emerg Med 1985; 14: 1–9PubMedCrossRefGoogle Scholar
  42. 42.
    Alter P, Tontsch D, Grimm W. Doxepin-induced torsade de pointes tachycardia. Ann Intern Med 2001; 135: 384–5PubMedGoogle Scholar
  43. 43.
    Davison ET. Amitriptyline-induced torsade de pointes: successful therapy with atrial pacing. J Electrocardiol 1985; 18: 299–301PubMedCrossRefGoogle Scholar
  44. 44.
    Crome P, Newman B. Fatal tricyclic antidepressant poisoning. J R Soc Med 1979; 72: 649–53PubMedGoogle Scholar
  45. 45.
    Hulten BA, Heath A. Clinical aspects of tricyclic antidepressant poisoning. Acta Med Scand 1983; 213: 275–8PubMedCrossRefGoogle Scholar
  46. 46.
    Pentel P, Sioris L. Incidence of late arrhythmias following tricyclic antidepressant overdose. J Toxicol Clin Toxicol 1981; 18: 543–8CrossRefGoogle Scholar
  47. 47.
    Desager JP, Leonard JP, Vanderbist M, et al. Reduced cardiac output and renal blood flow during amitriptyline intoxication in conscious rabbits. Toxicol Appl Pharmacol 1979; 47: 445–9PubMedCrossRefGoogle Scholar
  48. 48.
    Heard K, Cain BS, Dart RC, et al. Tricyclic antidepressants directly depress human myocardial mechanical function independent of effects on the conduction system. Acad Emerg Med 2001; 8: 1122–7PubMedCrossRefGoogle Scholar
  49. 49.
    Shannon M, Merola J, Lovejoy Jr FH. Hypotension in severe tricyclic antidepressant overdose. Am J Emerg Med 1988; 6: 439–42PubMedCrossRefGoogle Scholar
  50. 50.
    Foulke GE, Albertson TE, Walby WF. Tricyclic antidepressant overdose: emergency department findings as predictors of clinical course. Am J Emerg Med 1986; 4: 496–500PubMedCrossRefGoogle Scholar
  51. 51.
    Emerman CL, Connors Jr AF, Burma GM. Level of consciousness as a predictor of complications following tricyclic overdose. Ann Emerg Med 1987; 16: 326–30PubMedCrossRefGoogle Scholar
  52. 52.
    Matthew H, Lawson AAH. Acute barbiturate poisoning: a review of two years experience. Q J Med 1966; 35: 539–52Google Scholar
  53. 53.
    Hultén B-Å, Adams R, Askenasi R, et al. Predicting severity of tricyclic antidepressant overdose. J Toxicol Clin Toxicol 1992; 30: 161–70PubMedCrossRefGoogle Scholar
  54. 54.
    Foulke GE. Identifying toxicity risk early after antidepressant overdose. Am J Emerg Med 1995; 13: 123–6PubMedCrossRefGoogle Scholar
  55. 55.
    Caravati EM, Bossart PJ. Demographic and electrocardiographic factors associated with severe tricyclic antidepressant toxicity. J Toxicol Clin Toxicol 1991; 29: 31–43PubMedCrossRefGoogle Scholar
  56. 56.
    Ellison DW, Pentel PR. Clinical features and consequences of seizures due to cyclic antidepressant overdose. Am J Emerg Med 1989; 7: 5–10PubMedCrossRefGoogle Scholar
  57. 57.
    Lipper B, Bell A, Gaynor B. Recurrent hypotension immediately after seizures in nortriptyline overdose. Am J Emerg Med 1994; 12: 452–3PubMedCrossRefGoogle Scholar
  58. 58.
    Taboulet P, Michard F, Muszynski J, et al. Cardiovascular repercussions of seizures during cyclic antidepressant poisoning. J Toxicol Clin Toxicol 1995; 33: 205–11PubMedCrossRefGoogle Scholar
  59. 59.
    Boehnert MT, Lovejoy Jr FH. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med 1985; 313: 474–9PubMedCrossRefGoogle Scholar
  60. 60.
    Foulke GE, Albertson TE. QRS interval in tricyclic antidepressant overdosage inaccuracy as a toxicity indicator in emergency settings. Ann Emerg Med 1987; 16: 160–3PubMedCrossRefGoogle Scholar
  61. 61.
    Buckley NA, O’Connell DL, Whyte IM, et al. Interrater agreement in the measurement of QRS interval in tricyclic antidepressant overdose: implications for monitoring and research. Ann Emerg Med 1996; 28: 515–9PubMedCrossRefGoogle Scholar
  62. 62.
    Liebelt EL, Francis PD, Woolf AD. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med 1995; 26: 195–201PubMedCrossRefGoogle Scholar
  63. 63.
    Buckley NA, Chevalier S, Leditschke IA, et al. The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose. Crit Care 2003; 7: R101–7PubMedCrossRefGoogle Scholar
  64. 64.
    Petit JM, Spiker DG, Ruwitch JF, et al. Tricyclic antidepressant plasma levels and adverse effects after overdose. Clin Pharmacol Ther 1977; 21: 47–51PubMedGoogle Scholar
  65. 65.
    Spiker DG, Weiss AN, Chang SS, et al. Tricyclic antidepressant overdose: clinical presentation and plasma levels. Clin Pharmacol Ther 1975; 18: 539–46PubMedGoogle Scholar
  66. 66.
    Hanzlick RL. Postmortem blood concentrations of parent tricyclic antidepressant (TCA) drugs in 11 cases of suicide. Am J Forensic Med Pathol 1984; 5: 11–3PubMedCrossRefGoogle Scholar
  67. 67.
    Rudorfer MV. Cardiovascular changes and plasma drug levels after amitriptyline overdose. J Toxicol Clin Toxicol 1982; 19: 67–78PubMedCrossRefGoogle Scholar
  68. 68.
    Marshall JB. Tricyclic overdose. JAMA 1980; 244: 1900PubMedCrossRefGoogle Scholar
  69. 69.
    Amitai Y, Erickson T, Kennedy EJ, et al. Tricyclic antidepressants in red cells and plasma: correlation with impaired intraventricular conduction in acute overdose. Clin Pharmacol Ther 1993; 54: 219–27PubMedCrossRefGoogle Scholar
  70. 70.
    Bailey B, Buckley NA, Amre DK. A meta-analysis of prognostic indicators to predict seizures, arrhythmias or death after tricyclic antidepressant overdose. J Toxicol Clin Toxicol 2004; 42: 877–88PubMedCrossRefGoogle Scholar
  71. 71.
    Callaham M. Admission criteria for tricyclic antidepressant ingestion. West J Med 1982; 137: 425–9PubMedGoogle Scholar
  72. 72.
    Sedal L, Korman MG, Williams PO, et al. Overdosage of tricyclic antidepressants: a report of two deaths and a prospective study of 24 patients. Med J Aust 1972; 2: 74–9PubMedGoogle Scholar
  73. 73.
    Masters AB. Delayed death in imipramine poisoning. BMJ 1967; 3: 866–7PubMedCrossRefGoogle Scholar
  74. 74.
    McAlpine SB, Calabro JJ, Robinson MD, et al. Late death in tricyclic antidepressant overdose revisited. Ann Emerg Med 1986; 15: 1349–52PubMedCrossRefGoogle Scholar
  75. 75.
    Bloodworth L, Wilson A, Collins P, et al. Severe dothiepin intoxication: a report of two cases. Postgrad Med J 1984; 60: 442–4PubMedCrossRefGoogle Scholar
  76. 76.
    Babb SV, Dunlop SR. Case report of sudden and unexpected death after tricyclic overdose. Am J Psychiatry 1985; 142: 275–6PubMedGoogle Scholar
  77. 77.
    Chiu TF, Yang CC, Ger J, et al. Adult respiratory distress syndrome and late death following imipramine overdose: a case report. Chin Med J 1994; 54: 436–41Google Scholar

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  • H. K. Ruben Thanacoody
    • 1
    • 2
  • Simon H. L. Thomas
    • 1
    • 2
  1. 1.Wolfson Unit of Clinical Pharmacology, School of Clinical and Laboratory SciencesUniversity of NewcastleUK
  2. 2.National Poisons Information Service (Newcastle Centre)Newcastle upon TyneUK

Personalised recommendations